Skip to content

GENVOR INCORPORATED: 10-Q filed 2024-05-13

What GENVOR INCORPORATED reported in its quarterly report filed 2024-05-13 (fiscal Q2 2024): 25 published measures, 73 facts as tagged in accession 0001493152-24-018844.

This filing

Form
10-Q (quarterly report)
Filed
2024-05-13
Fiscal period
fiscal Q2 2024
Accession
0001493152-24-018844 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENVOR INCORPORATED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-03-3133,716USD
At 2023-09-3082,063USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-03-311,134,763USD
At 2023-09-301,787,059USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-03-31-1,101,047USD
At 2023-12-31-1,193,242USD
At 2023-09-30-1,704,996USD
At 2023-03-31-1,632,775USD
At 2022-12-31-1,424,063USD
At 2022-09-30-1,394,444USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-772,055USD91
2023-10-01 to 2024-03-31-2,123,482USD183
2023-10-01 to 2023-12-31-1,351,427USD92
2023-01-01 to 2023-03-31-221,212USD90
2022-10-01 to 2023-03-31-400,831USD182
2022-10-01 to 2022-12-31-179,619USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-862,031USD183
2022-10-01 to 2023-03-31-507,373USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-10-01 to 2024-03-31826,600USD183
2022-10-01 to 2023-03-31212,500USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-03-31-19,842,789USD
At 2023-09-30-17,719,307USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-01-01 to 2024-03-3119,669,477shares91
2023-10-01 to 2024-03-3119,596,756shares183
2023-01-01 to 2023-03-3118,381,710shares90
2022-10-01 to 2023-03-3120,449,202shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-01-01 to 2024-03-3119,669,477shares91
2023-10-01 to 2024-03-3119,596,756shares183
2023-01-01 to 2023-03-3118,381,710shares90
2022-10-01 to 2023-03-3120,449,202shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.04USD/shares91
2023-10-01 to 2024-03-31-0.11USD/shares183
2023-01-01 to 2023-03-31-0.01USD/shares90
2022-10-01 to 2023-03-31-0.02USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.04USD/shares91
2023-10-01 to 2024-03-31-0.11USD/shares183
2023-01-01 to 2023-03-31-0.01USD/shares90
2022-10-01 to 2023-03-31-0.02USD/shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-03-3114,818USD
At 2023-09-3015,734USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-03-31406,250USD91
2023-10-01 to 2024-03-311,313,350USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-747,400USD91
2023-10-01 to 2024-03-31-2,052,476USD183
2023-01-01 to 2023-03-31-155,282USD90
2022-10-01 to 2023-03-31-268,944USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-03-3118,898USD
At 2023-09-3066,329USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-01-01 to 2024-03-31481USD91
2023-10-01 to 2024-03-3116,832USD183
2023-01-01 to 2023-03-315,819USD90
2022-10-01 to 2023-03-3111,665USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-03-311,134,763USD
At 2023-09-301,787,059USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-01-01 to 2024-03-31747,400USD91
2023-10-01 to 2024-03-312,052,476USD183
2023-01-01 to 2023-03-31155,282USD90
2022-10-01 to 2023-03-31268,944USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-01-01 to 2024-03-3133,110USD91
2023-10-01 to 2024-03-3133,110USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-03-3120,094,608shares
At 2023-09-3019,061,936shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-03-3119,019,586USD
At 2023-09-3016,293,188USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-10-01 to 2024-03-312,123,482USD183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-10-01 to 2024-03-31916USD183
2022-10-01 to 2023-03-31916USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-24,655USD91
2023-10-01 to 2024-03-31-71,006USD183
2023-01-01 to 2023-03-31-65,930USD90
2022-10-01 to 2023-03-31-131,887USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-10-01 to 2024-03-31826,600USD183
2022-10-01 to 2023-03-31162,500USD182

Inspect the source

Entity
GENVOR INCORPORATED / CIK 0001792941
Captured
2026-09-21T17:27:40.419Z
SEC response SHA-256
3dda2e031208b06de0ad4f526a7b0b69c20a62c66e0a58841d63f8c48f29fe20

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001792941.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))